Peter Evan Harwin
Sits on 10 boards. Overboarded · 10 public boards Last updated September 28, 2026
Time on boards
- Boards served
- 10
- Current seats
- 10
- Board service
- 22 years
- Director since
- 2023
22 years of board service in total across 10 boards, counting each seat separately. Longest: Cogent Biosciences Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Oruka Therapeutics Inc. June 2, 202599.6%
-
Spyre Therapeutics Inc. May 29, 202582.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 9, 2026 | Damora Therapeutics Inc. | Option exercise | +5,809,000 | — | — |
| Feb 9, 2026 | Damora Therapeutics Inc. | Option exercise | +2,904,000 | — | — |
| Dec 4, 2025 | Crescent Biopharma Inc. | Open-market purchase | +1,360,000 | $13.41 | $18,237,600 |
| Oct 7, 2025 | Zenas BioPharma Inc. | Open-market purchase | +316,219 | $19.00 | $6,008,161 |
| Sep 16, 2024 | Zenas BioPharma Inc. | Derivative conversion | +41,130 | — | — |
| Sep 16, 2024 | Zenas BioPharma Inc. | Derivative conversion | +252,890 | — | — |
| Sep 16, 2024 | Zenas BioPharma Inc. | Derivative conversion | +709,794 | — | — |
| Sep 16, 2024 | Zenas BioPharma Inc. | Derivative conversion | +301,077 | — | — |
| Sep 16, 2024 | Zenas BioPharma Inc. | Open-market purchase | +300,000 | $17.00 | $5,100,000 |
| Apr 25, 2024 | Spyre Therapeutics Inc. | Option exercise | +3,639,680 | — | — |
| Sep 29, 2023 | Dianthus Therapeutics Inc. | Open-market purchase | +24,670 | $13.63 | $336,252 |
Questions about Peter Evan Harwin
What boards is Peter Evan Harwin on?
Peter Evan Harwin sits on the boards of Cogent Biosciences Inc., Crescent Biopharma Inc., Damora Therapeutics Inc., Dianthus Therapeutics Inc., Jade Biosciences Inc., Korsana Biosciences Inc., Oruka Therapeutics Inc., Spyre Therapeutics Inc., Viridian Therapeutics Inc. and Zenas BioPharma Inc.
How long has Peter Evan Harwin served on boards?
Our records show at least 22 years of board service across 10 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.